Alfuzosin Hydrochloride
ATC G04CA01 · 3 markets · 10 records
HK 7 records · 1 strengths
Records without a stated strength · 1 ALFURAL PROLONGED RELEASE TAB 10MG、ALFUZOSIN RIVOPHARM PROLONGED-RELEASE TABLETS 10MG、ALFUZOSIN SANDOZ PROLONGED RELEASE TABLETS 10MG、APO-ALFUZOSIN PROLONGED RELEASE TABLET 10mg、XALTRIN PROLONGED-RELEASE TABLETS 10MG、Xatral 2.5mg tablets
SG 2 records · 1 strengths
- 10 mgtablet · extended-releaseAPO-ALFUZOSIN PROLONGED RELEASE TABLET 10mgRANFUZOSIN MODIFIED RELEASE TABLETS 10MG
AU 1 records · 1 strengths
- 10 mgtablet · extended-releaseXATRAL SR alfuzosin 10mg (as hydrochloride) tablet blister pack
| Strength / form / release | AU | SG | HK |
|---|---|---|---|
| 10 mg tablet · extended-release | XATRAL SR alfuzosin 10mg (as hydrochloride) tablet blister pack | APO-ALFUZOSIN PROLONGED RELEASE TABLET 10mg RANFUZOSIN MODIFIED RELEASE TABLETS 10MG | |
unknown | ALFURAL PROLONGED RELEASE TAB 10MG ALFUZOSIN RIVOPHARM PROLONGED-RELEASE TABLETS 10MG ALFUZOSIN SANDOZ PROLONGED RELEASE TABLETS 10MG+3APO-ALFUZOSIN PROLONGED RELEASE TABLET 10mg XALTRIN PROLONGED-RELEASE TABLETS 10MG Xatral 2.5mg tablets |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.